Our thought bubble, via Axios tech editor Scott Rosenberg: Amazon's entry into the prescription market is a natural follow-on to its move (with Warren Buffett and JP Morgan Chase) into the broader healthcare field. But while that high-profile effort seems to be aimed, at least for now, at its own workforce, this acquisition is more likely to make big waves sooner in the competitive and huge drug market.
Inside the White House with D.C.'s most wired reporter. Sign up for Mike Allen's Axios AM.
More stories loading.